Report cover image

Cardiac Mapping Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034

Publisher Global Market Insights
Published Aug 11, 2025
Length 134 Pages
SKU # GMI20336993

Description

The Global Cardiac Mapping Market was valued at USD 3.4 billion in 2024 and is estimated to grow at a CAGR of 11.3% to reach USD 10.9 billion by 2034.

The market growth is driven by rising incidences of atrial fibrillation, increasing adoption of minimally invasive cardiac procedures, and technological advancements in electrophysiology. Cardiac mapping systems play a crucial role in diagnosing and treating complex cardiac arrhythmias by providing real-time visualization of the heart’s electrical activity. Innovations in 3D mapping technologies are enhancing precision and clinical outcomes, making these systems indispensable in modern cardiology. Additionally, growing awareness of early diagnosis and supportive reimbursement policies are expanding patient access, further fueling market growth globally.

The cardiac mapping market is primarily segmented by product type, with contact cardiac mapping systems leading in 2024, generating USD 3.01 billion. These systems are preferred for their accuracy in identifying arrhythmia sources and guiding ablation procedures effectively. Their ability to deliver high-resolution anatomical and electrical mapping provides cardiologists with detailed insights, enabling better decision-making during procedures. Contact systems are also seeing upgrades with integration of advanced catheters and AI-powered imaging, which improve efficiency and reduce procedure times, reinforcing their dominance in the market.

The atrial fibrillation segment accounted for the highest market revenue of USD 1.4 billion in 2024 and is poised to grow at a CAGR of 11.8%. The rising prevalence of AF worldwide, linked to aging populations, lifestyle changes, and growing cardiovascular risk factors, is significantly boosting demand for mapping systems. Since AF is the most common sustained arrhythmia requiring complex interventions, hospitals and specialty clinics are increasingly adopting advanced mapping technologies to improve treatment precision. This segment continues to expand with the development of multimodal approaches combining imaging, mapping, and ablation systems.

North America Cardiac Mapping Market generated USD 1.7 billion in 2024, supported by well-established healthcare infrastructure, rapid adoption of advanced electrophysiology technologies, and a high burden of cardiovascular diseases. The region benefits from strong collaborations between hospitals, research institutes, and medical device manufacturers, accelerating clinical adoption. The U.S. is witnessing rising procedural volumes in electrophysiology labs, supported by favorable reimbursement and physician training programs. This robust foundation positions North America as the leading market globally.

Key players such as Johnson & Johnson (Biosense Webster), Abbott Laboratories, Medtronic, Boston Scientific, and Acutus Medical are actively shaping the market through product innovation, strategic acquisitions, and global expansion. Companies are investing heavily in AI-powered mapping solutions, miniaturized catheters, and multimodal platforms that integrate mapping with imaging and ablation. Strategic collaborations with hospitals and academic institutions also play a vital role in clinical validation and accelerating adoption worldwide.

Table of Contents

134 Pages
Chapter 1 Methodology
1.1 Industry coverage
1.2 Market scope and definitions
1.3 Research design
1.4 Market size estimates and calculations
1.4.1 Approach 1: Company revenue share analysis
1.4.2 Approach 2: Based on number of EP procedures
1.4.3 Approach 3: Number of EP labs
1.5 Key trends for market estimates
1.6 Forecast model
1.7 Primary research & validation
1.7.1 Primary sources
1.7.2 Data mining sources
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 360 degree synopsis
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Type trends
2.1.5 Indication trends
2.1.6 End use trends
Chapter 3 Industry Insights
3.1 Industry ecosystem
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 High incidence of cardiovascular diseases
3.2.1.2 Rising awareness about the treatment options for cardiovascular diseases 37 Â3.2.1.3 Favorable government policies for research and funding
3.2.1.4 Technological advancements in the products
3.2.2 Industry pitfalls and challenges
3.2.2.1 High cost of the cardiac mapping systems
3.2.2.2 Lack of skilled and experienced electrophysiologists
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By type
3.3.3 By indication
3.3.4 By end use
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Trump administration tariff analysis
3.5.1 Trade impact
3.5.1.1 Trade volume disruptions
3.5.1.2 Country-wise response
3.5.2 Industry impact
3.5.2.1 Supply-side impact (raw materials)
3.5.2.1.1 Price volatility in key materials
3.5.2.1.2 Supply chain restructuring
3.5.2.1.3 Production cost implications
3.5.2.2 Demand-side impact (Cost to consumers)
3.5.2.2.1 Price transmission to end markets
3.5.2.2.2 Market share dynamics
3.5.2.2.3 Consumer response patterns
3.5.3 Key companies impacted
3.5.4 Strategic industry responses
3.5.4.1 Supply chain reconfiguration
3.5.4.2 Pricing and product strategies
3.5.5 Outlook and future considerations
3.6 Reimbursement scenario
3.6.1 U.S.
3.6.2 Europe
3.7 Technology landscape
3.8 Gap analysis
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape
4.1 Introduction
4.1.1 Johnson & Johnson (Biosense Webster)
4.1.2 Abbott Laboratories
4.1.3 Boston Scientific
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Cardiac Mapping Market, By Product
5.1 Mapping catheters
5.2 Mapping systems
Chapter 6 Cardiac Mapping Market, By Type
6.1 Contact cardiac mapping
6.2 Non-contact cardiac mapping
Chapter 7 Cardiac Mapping Market, By Indication
7.1 Atrial fibrillation
7.2 Atrial flutter
7.3 Ventricular tachycardia
7.4 Other indications
Chapter 8 Cardiac Mapping Market, By End Use
8.1 Hospitals
8.2 EP labs
8.3 Other end users
Chapter 9 Cardiac Mapping Market, By Region
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Latin America
9.5 Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Financial Data
10.1.2 Product Landscape
10.1.3 Strategy Outlook
10.1.4 SWOT Analysis
10.2 APN Health, LLC
10.2.1 Financial Data
10.2.2 Product Landscape
10.2.3 SWOT Analysis
10.3 Boston Scientific Corporation
10.3.1 Financial Data
10.3.2 Product Landscape
10.3.3 Strategy Outlook
10.3.4 SWOT Analysis
10.4 EnChannel Medical
10.4.1 Financial Data
10.4.2 Product Landscape
10.4.3 Strategic Outlook
10.4.4 SWOT Analysis
10.5 Integer Holdings Corporation
10.5.1 Financial Data
10.5.2 Product Landscape
10.5.3 SWOT Analysis
10.6 Johnson & Johnson
10.6.1 Financial Data
10.6.2 Product Landscape
10.6.3 Strategy Outlook
10.6.4 SWOT Analysis
10.7 Kardium
10.7.1 Financial Data
10.7.2 Product Landscape
10.7.3 SWOT Analysis
10.8 Lepu Medical Technology (Beijing)Co., Ltd.
10.8.1 Financial Data
10.8.2 Product Landscape
10.8.3 SWOT Analysis
10.9 Medtronic plc
10.9.1 Financial Data
10.9.2 Product Landscape
10.9.3 Strategy Outlook
10.9.4 SWOT Analysis
10.10 MicroPort Scientific Corporation
10.10.1 Financial Data
10.10.2 Product Landscape
10.10.3 Strategic Outlook
10.10.4 SWOT Analysis

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us